El Ministerio de Salud, Trabajo y Bienestar de Japón otorga la designación de medicamento huérfano a tagraxofusp para tratar la neoplasia de células dendríticas plasmocitoides blásticas (BPDCN) FLORENCIA, Italia y NUEVA YORK, 30 de agosto de 2023 /PRNewswire/ — Menarini Group…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.